FDB Response to Public Health England Prescribed Medicines Review - Technology Role

First DatabankCommenting on findings and recommendations from Public Health England's review into dependence and withdrawal associated with some prescribed medicines, Darren Nichols, UK managing director, FDB (First Databank), said:

"This extensive review by Public Health England underlines the challenges particularly within the primary care system to ensure that clinical guidance is effectively adhered to, with regular reviews with patients, and that prescribing is made safer.

"Its recommendation on greater prescribing transparency and accountability through increasing the availability and use of prescribing data for medicines that can cause dependence or withdrawal highlights the crucial role that technology can play in supporting GPs and other members of the primary care multi-disciplinary team.

"Although not heavily featured in the review, technology is having a big impact on primary care prescribing. Today we are working with more than 4,000 GP practices, with a patient population of 35 million, across two thirds of England’s clinical commissioning groups (CCGs) who are making significant strides in changing prescribing practice, by drawing on technology at the point of prescribing. This enables clinicians to be alerted when a prescribing decision might not comply with clinical best practice or when it might not be most appropriate for the individual patient. This has already seen thousands of GPs choose alternative medications for their patients millions of times.

"Technology like this will continue to be an essential support for GPs, and to CCGs, in helping to distil current and improved guidance around medicines examined in Public Health England’s report, and in adhering to it when appropriate. This can help to ensure greater compliance with guidance, whilst ensuring professionals remain in control of informed prescribing decisions.

"Similar technologies may also now be needed for practice pharmacists and other members of the multi-disciplinary care environment, to take an active role in identifying patient cohorts and proactively reviewing their medication."

About FDB

FDB (First Databank), part of the Hearst Health network, is the leading provider of drug knowledge that helps healthcare professionals make precise decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver valuable, useful, and differentiated solutions. We offer four decades of experience in transforming medical knowledge into actionable, targeted, and effective solutions that help improve patient safety, operational efficiency, and healthcare outcomes.

Most Popular Now

Open Call HORIZON-HLTH-2021-TOOL-06-03: …

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 5 "Unlocking the full potential of new tools, technologies and digital...

CSAM Acquires Optima - Further Boosts eH…

CSAM Health Group AS ("CSAM"), the leading provider of niche eHealth solutions in the Nordics, today announced it has signed a deal to acquire eHealth player Optima Corporation Ltd from...

Novartis and Hewlett Packard Enterprise …

Novartis and Hewlett Packard Enterprise (HPE)announced a collaboration that aims to accelerate the use of data and digital technologies within Novartis efforts to reimagine global health and improve access to...

COVID-19 Origins Still a Mystery

Scientists using computer modelling to study SARS-CoV-2, the virus that caused the COVID-19 pandemic, have discovered the virus is most ideally adapted to infect human cells - rather than bat...

Using Artificial Intelligence to Overcom…

Depression is a worldwide problem, with serious consequences for individual health and the economy, and rapid and effective screening tools are thus urgently needed to counteract its increasing prevalence. Now...

Deep Machine Learning Completes Informat…

The Structural Bioinformatics and Network Biology laboratory, led by ICREA Researcher Dr. Patrick Aloy, has completed the bioactivity information for a million molecules using deep machine-learning computational models. It has...

EU Digital COVID Certificate Enters into…

The EU Digital COVID Certificate Regulation enters into application. This means that EU citizens and residents will now be able to have their Digital COVID Certificates issued and verified across...

Philips and the Spanish National Center …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has participated in an important research project to develop a magnetic resonance (MR) imaging technique [1,2] that could...

Scottish Health and Care Professionals G…

Scottish health and care professionals across a wide range of clinical settings including NHS Scotland health boards are being given access to an individual's COVID-19 vaccine status through the Orion...

Ethics and Governance of Artificial Inte…

Artificial Intelligence (AI) refers to the ability of algorithms encoded in technology to learn from data so that they can perform automated tasks without every step in the process having...

It's Going to be Quite a Handover…

Health and social care secretary Matt Hancock has been abruptly replaced by Sajid Javid. The Highland Marketing advisory board consider the huge agenda he is now facing, and what it...

Philips Accelerates Stroke Diagnosis and…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced a strategic partnership agreement with NICO.LAB, a MedTech stroke care company. Together with the recently expanded stroke...